AERD Risk Assessment Tool
This tool helps you determine your risk of having Aspirin-Exacerbated Respiratory Disease (AERD) based on your symptoms and medical history. AERD is a condition where asthma, nasal polyps, and NSAID sensitivity occur together.
Assessment Questions
Answer the following questions about your medical history and symptoms. This assessment is not a diagnosis but can help you discuss your symptoms with a specialist.
Your Assessment Results
Recommendations
For many people with asthma, taking a simple pain reliever like ibuprofen or aspirin can trigger a dangerous reaction - not just a stomachache, but a full-blown asthma attack, blocked sinuses, and even trouble breathing. This isn’t a rare allergy. It’s a specific, underdiagnosed condition called Aspirin-Exacerbated Respiratory Disease (a chronic condition where asthma, chronic sinusitis with nasal polyps, and sensitivity to aspirin and NSAIDs occur together), or AERD. If you’ve had recurring nasal polyps, worsening asthma after taking pain meds, or reactions to wine or beer, this could be why.
What Exactly Is AERD?
AERD isn’t just an allergy to aspirin. It’s a systemic inflammatory disorder that affects the lungs, sinuses, and airways. It’s defined by three things happening at once: persistent asthma, chronic sinus infections with nasal polyps, and a reaction to medications that block the COX-1 enzyme - including aspirin, ibuprofen, naproxen, and other NSAIDs. This triad is so distinctive that doctors sometimes call it Samter’s Triad, named after the doctor who first described it in the 1960s.
Unlike typical allergies, AERD doesn’t involve IgE antibodies. Instead, it’s driven by a chemical imbalance in the body’s inflammatory pathways. When COX-1 is blocked, the body shifts toward overproducing leukotrienes - powerful inflammatory molecules - while underproducing protective prostaglandins. This leads to swelling in the airways, mucus overproduction, and intense inflammation in the sinuses. The result? Severe, hard-to-control asthma and polyps that keep coming back after surgery.
Who Gets AERD?
AERD almost always starts in adulthood - usually between ages 20 and 50. It’s rare in children. About 9% of all adults with asthma have AERD, but the number jumps to 30% if they also have nasal polyps. That’s a huge red flag. If you’re an adult with asthma and polyps, you should be tested.
It’s not inherited. There’s no genetic test. But it’s more common in people with a history of chronic sinus disease or severe asthma. Women are slightly more likely to be affected than men. And while it can happen to anyone, delays in diagnosis are common - on average, people wait 7 to 10 years before getting the right diagnosis, according to research from Harvard Medical School.
What Happens When You Take NSAIDs?
For someone with AERD, even a single tablet of Advil or Aleve can trigger symptoms within 30 to 120 minutes. The reaction is predictable and consistent:
- Severe nasal congestion (95% of reactions)
- Frontal headache or sinus pressure (88%)
- Watery or red eyes (76%)
- Wheezing, chest tightness, shortness of breath (92%)
- Flushing, nausea, or abdominal pain in some cases
These aren’t mild side effects. They’re acute respiratory events that can land someone in the ER. In fact, AERD patients visit the emergency room 2.3 times more often than other asthma patients, and are hospitalized 1.8 times more frequently.
The Alcohol Connection
One of the most overlooked signs of AERD is sensitivity to alcohol. About 75% of patients - three out of four - have reactions after drinking wine, beer, or spirits. It’s not just a hangover. It’s sudden nasal blockage, coughing, or wheezing after just one drink. Many patients report this for years before anyone connects it to their asthma and polyps. Even more surprising: red wine and whiskey are the most common triggers, but clear spirits like vodka can also cause issues. This isn’t about sulfites or histamines - it’s the same underlying inflammatory pathway being activated.
Why Standard Asthma Treatments Often Fail
Most asthma patients control their symptoms with inhalers - corticosteroids, bronchodilators, or combination therapy. But in AERD, these often don’t work well. Only about 35% of patients achieve good control with inhalers alone. Why? Because the problem isn’t just airway narrowing - it’s constant, deep inflammation in the sinuses and lower airways fueled by leukotrienes. Standard inhalers don’t touch that.
Nasal polyps in AERD patients are also more aggressive. They grow larger, come back faster, and require multiple surgeries. Studies show that 70-100% of AERD patients have polyp recurrence within 18 months of surgery, compared to 30-40% in people without AERD. That’s why many end up having five, six, or even more sinus operations over their lifetime.
The Game-Changer: Aspirin Desensitization
Here’s the surprising truth: the best long-term treatment for AERD is taking aspirin - daily, for life. This sounds crazy, but it’s backed by decades of research. The process is called aspirin desensitization.
Under medical supervision, patients are given gradually increasing doses of aspirin over 1-3 days in a controlled hospital setting. Once the full dose is tolerated, they continue taking 650 mg twice daily. The result? In 85% of patients, asthma symptoms improve. Sinus inflammation drops. Polyp regrowth slows dramatically - from every 6 months to every 2-3 years. Emergency visits and surgeries drop by up to 60%.
It’s not risk-free. About 42% of patients experience mild to moderate reactions during the desensitization process. But with proper monitoring, serious complications are rare. The key is doing it right - in a specialized center with staff trained in AERD protocols.
What About Biologics Like Dupixent?
In recent years, biologic drugs like dupilumab (Dupixent) have become another tool. Approved for chronic sinusitis with nasal polyps in 2019, it targets the IL-4 and IL-13 pathways that drive Type 2 inflammation - the same ones overactive in AERD.
Studies show dupilumab reduces polyp size by 50-60% and improves breathing in many patients. But it’s expensive - around $38,500 a year - and only 38% of AERD patients have insurance coverage. It’s also not a cure. You need to keep taking it indefinitely. For many, it’s used alongside aspirin desensitization, not instead of it.
Why Diagnosis Is So Hard - And So Important
Most primary care doctors, and even some allergists, don’t know about AERD. Patients often hear, “You’re just sensitive to painkillers,” or “Your polyps are just allergies.” But AERD isn’t an allergy - it’s a disease with a clear pattern. If you’re an adult with asthma, nasal polyps, and NSAID reactions, you need to see an AERD specialist.
There are only about 35 AERD-specialized centers in the U.S., mostly at major academic hospitals. Finding one can be hard. Patient forums like the Samter’s Society report that 65% of people struggle to find knowledgeable doctors. Average ratings for general practitioners treating AERD patients are 2.8 out of 5 - compared to 4.3 for specialists.
And delays have real consequences. Undiagnosed patients often undergo unnecessary surgeries, miss out on life-changing treatments, and live with poor quality of life. One patient on Reddit said it took 11 years and four ENT specialists before someone finally connected the dots.
What You Should Do If You Suspect AERD
If you’ve got asthma, nasal polyps, and reactions to NSAIDs or alcohol, here’s what to do:
- Stop taking aspirin, ibuprofen, naproxen, and other NSAIDs until you’re evaluated.
- See an allergist or immunologist who specializes in AERD - not just any allergy clinic.
- Ask about aspirin challenge testing or desensitization.
- Track your alcohol reactions - even small amounts matter.
- Get a CT scan of your sinuses if you haven’t already.
- Consider biologics if desensitization isn’t an option or doesn’t fully help.
Education is critical. Patients need 4-6 sessions to fully understand their condition. The Samter’s Society offers free, detailed resources - including videos and patient guides - that are rated 4.5 out of 5 by users.
The Future of AERD Treatment
Research is moving fast. In 2023, the FDA gave breakthrough status to MN-001 (lodadustat), a new drug that blocks leukotriene production. Early trials show a 70% drop in polyp recurrence. A national patient registry is now tracking 2,000 AERD cases to better understand long-term outcomes.
By 2028, experts predict precision medicine - targeting specific inflammatory molecules - will cut sinus surgeries by 40%. But progress won’t be equal. Black and Hispanic patients face 3.2 years longer delays in diagnosis than white patients. Closing that gap is one of the biggest challenges ahead.
Bottom Line
AERD is not a rare oddity - it’s a serious, underdiagnosed condition affecting over a million Americans. It’s not about being allergic to painkillers. It’s about a deeper, systemic inflammation that affects your lungs, sinuses, and quality of life. If you’ve been struggling with asthma that won’t improve, polyps that keep returning, or reactions to aspirin or wine - don’t wait. Get tested. You might be one step away from a treatment that changes everything.
Can you have AERD without nasal polyps?
No. Nasal polyps are one of the three required features of AERD. If you have asthma and NSAID sensitivity but no polyps, you likely have a different condition. Polyps are a key diagnostic marker - their presence helps distinguish AERD from other forms of asthma or drug sensitivity.
Is it safe to take Tylenol (acetaminophen) if you have AERD?
Yes. Acetaminophen (Tylenol) does not inhibit COX-1 the same way aspirin and NSAIDs do, so it’s generally safe for AERD patients. However, some individuals may still react to high doses (over 1,000 mg), so it’s best to start with a low dose and monitor for symptoms. Always consult your specialist before making changes.
Does AERD get worse over time?
Left untreated, AERD tends to worsen. Nasal polyps grow larger, asthma becomes harder to control, and sinus infections become more frequent. But with proper management - especially aspirin desensitization - progression can be significantly slowed or even halted. Early diagnosis is the biggest factor in long-term outcomes.
Can children develop AERD?
AERD is extremely rare in children. It almost always begins in adulthood, between ages 20 and 50. If a child has asthma and reactions to NSAIDs, other conditions - like eosinophilic esophagitis or non-AERD drug hypersensitivity - are more likely. AERD is not considered a pediatric condition.
What if I can’t tolerate aspirin desensitization?
If desensitization isn’t possible due to side effects or medical reasons, biologic therapies like dupilumab (Dupixent) are the next best option. They reduce inflammation, shrink polyps, and improve breathing. While not a cure, they can significantly improve quality of life. Some patients use both - desensitization for long-term control and biologics for breakthrough symptoms.
How do I find an AERD specialist near me?
Start by contacting the Samter’s Society or the American College of Allergy, Asthma & Immunology. They maintain lists of certified AERD centers, mostly located at major university hospitals. In the U.S., there are about 35 specialized centers. If you’re outside the U.S., ask your allergist to refer you to a center with experience in aspirin desensitization and Type 2 inflammatory disease.
Author
Mike Clayton
As a pharmaceutical expert, I am passionate about researching and developing new medications to improve people's lives. With my extensive knowledge in the field, I enjoy writing articles and sharing insights on various diseases and their treatments. My goal is to educate the public on the importance of understanding the medications they take and how they can contribute to their overall well-being. I am constantly striving to stay up-to-date with the latest advancements in pharmaceuticals and share that knowledge with others. Through my writing, I hope to bridge the gap between science and the general public, making complex topics more accessible and easy to understand.